Rapid Micro Biosystems, Inc. (RPID)
Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables.
We are leading a global transformation toward fully automated microbial quality control within pharmaceutical manufacturing. Our flagship Growth Direct platform brings the quality control lab to the manufacturing floor, unlocking the power of in-line/at-the-line microbial quality control, or MQC, automation to deliver faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that our customers rely on to ensure safe and consistent supply of important healthcare products.
Through our unique expertise at the intersection of microbiology, robotic systems, and advanced vision algorithms, we are setting the foundation for end-to-end quality control automation to enable the future of advanced pharmaceutical manufacturing.
|IPO Date||Jul 15, 2021|
|Industry||Wireless Telecommunication Services|
1001 Pawtucket Boulevard West, Suite 280
Lowell, MA 01854
|Fiscal Year||January - December|
|Reporting Currency||US Dollars|
|Robert G. Spignesi Jr.||Chief Executive Officer, President and Director|
|Sean M. Wirtjes||Chief Financial Officer, Treasure and Secretary|
|Victoria Vezina||Chief Human Resources Officer|
|John J.Addington Wilson||Chief Operating Officer|
|Jonathan Paris||Senior Vice President and General Counsel|
|Scott White||Vice President of Global Sales|
|Gurinder Grewal||Senior Vice President of Strategy|